| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $174.6M | +6.1% |
| R&D Expense | $253.6M | +27.1% |
| SG&A Expense | $53.4M | +12.4% |
| Operating Income | -$132.4M | -60.5% |
| Interest Expense | $6.2M | — |
| Pre-tax Income | -$119.6M | -119.5% |
| Income Tax | $13.7M | +1930.0% |
| Net Income | -$133.1M | -141.3% |
| EPS (Basic) | -$2.20 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $53.8M | -0.3% |
| Accounts Receivable | $23.7M | -18.1% |
| Current Assets | $635.6M | -5.9% |
| Total Assets | $965.1M | +14.0% |
| Current Liabilities | $73.9M | +15.8% |
| Long-term Debt | $161.8M | — |
| Total Liabilities | $303.0M | +155.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$77.9M | -418.3% |
| Capital Expenditures | $18.4M | -52.1% |
| Investing Cash Flow | -$111.1M | +7.2% |
| Financing Cash Flow | $189.2M | +3218.5% |
| Free Cash Flow | -$96.4M | -587.9% |
| -136.6% |
| EPS (Diluted) | -$2.20 | -136.6% |
| Stockholders' Equity |
| $661.8M |
| -9.0% |